Skip to content

Blastocyst Transfer Selection in Women with Advanced Maternal Age, Previous Miscarriage, or Implantation Failure: A Prospective Study

Blastocyst Transfer Selection in Women with Advanced Maternal Age, Previous Miscarriage, or Implantation Failure: A Prospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108378
Enrollment
Unknown
Registered
2025-08-29
Start date
2025-09-03
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Experimental group: NICS + Morphological Assessment:Patients undergoing blastocyst frozen embryo transfer (FET) cycles will undergo single frozen blastocyst transfer selected based on morphologica
Control group: Morphological Assessment:Patients undergoing blastocyst frozen embryo transfer (FET) cycles will undergo single frozen blastocyst transfer selected based on morphological grading

Sponsors

General Hospital of Eastern Theater Command, People's Liberation Army of China
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 42 Years

Inclusion criteria

Inclusion criteria: 1 Female patients aged 35–42 years or with prior pregnancy loss or a history of embryo implantation failure; 2 IVF/ICSI treatment cycle; 3 Planned single blastocyst transfer; 4 Voluntary participation with signed informed consent.

Exclusion criteria

Exclusion criteria: 1PGT (Preimplantation Genetic Testing) cycles; 2 Female medical history of: (1). Thyroid disorders ;(2). Adrenal diseases; (3). Sexually transmitted infections ;(4). Genetic disorders;(5). Psychiatric or psychological disorders ; 3 Uterine abnormalities, including: Uterine malformations (e.g., unicornuate uterus, didelphic uterus), untreated septate uterus, adenomyosis, submucosal fibroids, endometrial polyps, or intrauterine adhesions (including history of Asherman’s syndrome). Note: Patients with treated conditions may be included; 4 Contraindications to ART or pregnancy, such as: Poorly controlled type I/II diabetes, Undiagnosed or impaired hepatic/renal function (based on blood tests), Deep vein thrombosis (DVT) or pulmonary embolism (PE), History of cerebrovascular accident (CVA),Uncontrolled hypertension, Cardiac disease,Active malignancy,Severe anemia,Unexplained vaginal bleeding.

Design outcomes

Primary

MeasureTime frame
Ongoing pregnancy rate;Miscarriage rate;

Secondary

MeasureTime frame
Clinical pregnancy rate;Live birth rate;Cumulative clinical pregnancy rate ;Cumulative onging pregnancy rate ;Cumulative live birth rate ;Cumulative miscarriage rate ;

Countries

China

Contacts

Public ContactLi Chen

General Hospital of Eastern Theater Command, People's Liberation Army of China

chenli1978@nju.edu.cn+86 138 5182 8017

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026